Compare UVV & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UVV | STAA |
|---|---|---|
| Founded | 1886 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1994 | 1995 |
| Metric | UVV | STAA |
|---|---|---|
| Price | $53.51 | $29.74 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $22.81 |
| AVG Volume (30 Days) | 298.5K | ★ 590.8K |
| Earning Date | 05-28-2026 | 05-12-2026 |
| Dividend Yield | ★ 6.25% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.30 | 0.10 |
| Revenue | ★ $2,885,078,000.00 | $239,442,000.00 |
| Revenue This Year | $0.67 | $30.82 |
| Revenue Next Year | $0.10 | $8.41 |
| P/E Ratio | ★ $40.90 | $312.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $49.19 | $15.59 |
| 52 Week High | $59.38 | $35.87 |
| Indicator | UVV | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 52.38 | 51.13 |
| Support Level | $51.57 | $28.10 |
| Resistance Level | $54.14 | $31.05 |
| Average True Range (ATR) | 1.07 | 1.13 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 72.10 | 44.83 |
Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.